July 24, 2026

Sonida Senior Living, Inc. (SNDA) Stock Report: Navigating Growth in Senior Care with a 38.5% Revenue Surge

Sonida Senior Living, Inc. (SNDA) stands at the forefront of the senior housing industry in the United States, offering a comprehensive suite of services to aging adults, from independent and..

Bicycle Therapeutics plc (BCYC) Stock Report: Exploring a 226% Potential Upside in the Biotechnology Sector

Bicycle Therapeutics plc (BCYC), a clinical-stage biopharmaceutical company, is garnering attention from investors for its innovative approach to tackling diseases that current therapeutics struggle to address. Headquartered in Cambridge, United..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Biotech Play with Mixed Signals and Growth Potential

Fortrea Holdings Inc. (NASDAQ: FTRE) is navigating the intricate landscape of the biotechnology industry with a focus on providing comprehensive research solutions for biopharmaceutical and medical device development. Incorporated in..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Navigating a 52.40% Potential Upside in the Biotech Sector

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company headquartered in New Haven, Connecticut, has captured investor attention with its promising therapeutic innovations in the healthcare sector. Specializing in the..

Personalis, Inc. (PSNL) Investor Outlook: Analyzing Growth Potential Amidst a 13.54% Upside

Personalis, Inc. (NASDAQ: PSNL), a notable player in the healthcare sector specializing in cancer genomics, is making waves in the diagnostics and research industry. As investors turn their attention to..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Assessing Growth Potential Amid a Challenging Market Landscape

Treace Medical Concepts, Inc. (NASDAQ: TMCI) is a medical technology firm focused on innovative solutions for bunion deformity correction. Despite its niche specialization in the healthcare sector, the company is..

AnaptysBio, Inc. (ANAB) Investor Outlook: Exploring a 58.61% Potential Upside

AnaptysBio, Inc. (ANAB), a clinical-stage biotechnology firm rooted in San Diego, is making waves in the healthcare sector with its promising pipeline of immunology therapeutics. As the company focuses on..

KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis: Understanding the Unchanged Landscape in Biotech

KalVista Pharmaceuticals, Inc. (KALV), a key player in the biotechnology sector, operates from its headquarters in Framingham, Massachusetts. As a company dedicated to developing groundbreaking oral therapies for rare diseases,..

InMode Ltd. (INMD): Investor Outlook Highlights Strong Global Presence and Growth Potential

InMode Ltd. (NASDAQ: INMD), an innovative player in the healthcare sector, continues to capture investor attention with its robust portfolio of minimally invasive aesthetic medical products. Headquartered in Yokne’am, Israel,..

Tectonic Therapeutic, Inc. (TECX): Analyst Ratings Signal a Potential 148% Upside for Innovative Biotech Player

Tectonic Therapeutic, Inc. (NASDAQ: TECX) has emerged as a fascinating player in the biotechnology sector, capturing investor attention with its cutting-edge approach to drug discovery and development. Specializing in therapeutic..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating a 7.19% Potential Upside in the Biotech Sector

Investors eyeing the biotechnology sector may find Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) an intriguing, albeit challenging, opportunity. With a market capitalization of $518.02 million, this Boston-based biotech firm is..

COMPASS Pathways Plc (CMPS) Stock Analysis: A 109% Potential Upside in the Psychedelic Therapeutics Space

For investors exploring opportunities in the burgeoning field of mental health therapeutics, COMPASS Pathways Plc (NASDAQ: CMPS) presents an intriguing proposition. Specializing in innovative psychedelic therapies, this UK-based biotechnology company..

Arbutus Biopharma (ABUS): A Promising Biotech with Over 15% Potential Upside

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company headquartered in Warminster, Pennsylvania, has captured the attention of investors with its promising pipeline and significant potential upside. Specializing in novel..

Akso Health Group (AHG) Stock Analysis: Exploring Challenges and Opportunities in the Evolving Healthcare Market

Investors with a keen eye on the healthcare sector, particularly in the expansive Chinese market, might find Akso Health Group (NASDAQ: AHG) an intriguing, albeit complex, investment case. With a..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: A 40.40% Revenue Growth Story with Double-Digit Upside

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a burgeoning player in the healthcare sector, is rapidly making its mark in the niche market of rare disease treatments. With a market capitalization of..

Zenas BioPharma, Inc. (ZBIO): Investor Outlook with 35.93% Potential Upside

Zenas BioPharma, Inc. (NASDAQ: ZBIO), a prominent player in the biotechnology sector, offers an intriguing prospect for investors seeking exposure to the healthcare industry. With a market capitalization of $1.96..

Beta Bionics, Inc. (BBNX) Stock Analysis: A 22.75% Potential Upside in the Healthcare Sector

Beta Bionics, Inc. (NASDAQ: BBNX) is making waves in the medical devices industry with its innovative approach to diabetes management. The company, headquartered in Irvine, California, is at the forefront..

Replimune Group, Inc. (REPL) Stock Analysis: Assessing the 1.98% Potential Upside in Biotech

Replimune Group, Inc. (NASDAQ: REPL), a burgeoning player in the biotechnology sector, offers investors a unique opportunity to explore innovative cancer therapies through its cutting-edge oncolytic immunotherapies. This Woburn, Massachusetts-based..

Claritev Corporation (CTEV) Stock Analysis: Exceptional Growth Potential with a 61.87% Upside

Claritev Corporation (NASDAQ: CTEV), a key player in the healthcare sector, is making waves with its comprehensive data analytics and cost management solutions. With a market cap of $396.7 million,..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Challenges in the Healthcare Staffing Sector

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands at a critical juncture, as it navigates the complexities of the healthcare staffing industry. With a market capitalization of $428.06 million, this Florida-based..

Search

Funds

July 24, 2026

Search

Funds

July 24, 2026

FTSE 100

Funds